| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 271.68M | 275.46M | 262.08M | 251.43M | 223.93M | 165.09M |
| Gross Profit | 32.04M | 34.69M | 31.70M | 31.45M | 29.92M | 20.92M |
| EBITDA | 4.20M | 5.11M | 3.25M | 6.75M | 7.32M | 4.55M |
| Net Income | -680.00K | 176.00K | -1.20M | 2.52M | 3.00M | 1.41M |
Balance Sheet | ||||||
| Total Assets | 96.14M | 101.71M | 99.54M | 100.03M | 84.49M | 94.82M |
| Cash, Cash Equivalents and Short-Term Investments | 2.44M | 3.76M | 438.00K | 4.23M | 2.76M | 5.74M |
| Total Debt | 14.21M | 37.09M | 35.80M | 33.58M | 27.23M | 23.25M |
| Total Liabilities | 66.13M | 71.79M | 70.81M | 68.37M | 49.76M | 67.23M |
| Stockholders Equity | 30.01M | 29.92M | 28.74M | 31.66M | 34.73M | 27.59M |
Cash Flow | ||||||
| Free Cash Flow | -2.31M | -1.37M | -2.46M | 3.33M | 553.00K | 6.33M |
| Operating Cash Flow | -1.07M | -303.00K | 119.00K | 4.24M | 3.39M | 6.72M |
| Investing Cash Flow | 3.65M | 3.83M | -2.33M | -716.00K | -2.65M | -209.00K |
| Financing Cash Flow | -2.21M | -208.00K | -1.57M | -2.05M | -3.71M | -2.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £188.44M | 3.31 | 4.55% | 3.22% | -0.17% | -10.96% | |
70 Outperform | £2.80B | 10.60 | 23.83% | 3.44% | -15.99% | 69.97% | |
67 Neutral | £294.13M | 5.52 | -6.79% | 6.30% | 3.31% | -340.97% | |
62 Neutral | £17.66M | 4.36 | 30.82% | ― | -18.51% | -13.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £103.93M | 12.59 | 17.19% | 1.48% | 20.64% | ― | |
49 Neutral | £10.91M | -4.86 | -2.26% | 2.41% | 2.30% | 37.27% |